Exhibit 99.1
AGREEMENT OF JOINT FILING
The undersigned hereby agree that the Schedule 13G with respect to the ordinary shares, NIS 0.01 par value per share, of Vascular Biogenics Ltd. is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: February 1, 2022 | Regals Capital Management LP |
By: Regals Capital Holdings LLC, its general partner | |
/s/ David M. Slager | |
Name: David M. Slager | |
Title: Managing Member | |
Dated: February 1, 2022 | Regals Fund LP |
By: Regals Fund GP LLC, its general partner | |
/s/ David M. Slager | |
Name: David M. Slager | |
Title: Managing Member | |
Dated: February 1, 2022 | David M. Slager |
/s/ David M. Slager | |
Name: David M. Slager |